Sage Journals: Discover world-class research

Retricted access

Review article

First published 2005-05

Review: Development and therapeutic potential of incretin hormone analogues for type 2 diabetes

Brian D Green, Nigel Irwin, Victor A Gault [...]

The British Journal of Diabetes & Vascular Disease

Retricted access

Research article

First published 1999-09

Control of Glucose Homeostasis by Incretin Hormones

Riccardo Perfetti, Traci A. Brown, Rita Velikina [...]

Diabetes Technology & Therapeutics

Retricted access

Research article

First published 2007-1

The Physiology of Incretin Hormones and the Basis for DPP-4 Inhibitors

Skye Aiko McKennon, R. Keith Campbell

The Science of Diabetes Self-Management and Care

Open access

Research article

First published 2011

Saxagliptin: A Selective DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus

Jay Shubrook, Randall Colucci, Aili Guo [...]

Clinical Medicine Insights: Endocrinology and Diabetes

Retricted access

Review article

First published 2006-07

Review: Inhibition of dipeptidyl peptidase-4 with vildagliptin: a potential new treatment for type 2 diabetes

Richard E Pratley, Afshin Salsali, Glenn Matfin

The British Journal of Diabetes & Vascular Disease

Free access

Research article

First published 2006-12

Dipeptidyl peptidase IV (DPP IV) inhibitors: a newly emerging drug class for the treatment of type 2 diabetes

Brian D Green, Peter R Flatt, Clifford J Bailey

Diabetes & Vascular Disease Research

Retricted access

Other

First published 2025-6

Use of incretin-based therapies in women using hormone replacement therapy (HRT)

Annice Mukherjee, Sadaf Ghaem-Maghami, Akheel A Syed

Post Reproductive Health

Open access

Review article

First published 2020

Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism

Natasha A Trzaskalski, Evgenia Fadzeyeva, Erin E Mulvihill

Clinical Medicine Insights: Endocrinology and Diabetes

Retricted access

Research article

First published 2006-06

Incretin Mimetics and Dipeptidyl Peptidase-IV Inhibitors: A Review of Emerging Therapies for Type 2 Diabetes

David M. Kendall, Dennis Kim, David Maggs

Diabetes Technology & Therapeutics

Free access

Review article

First published 2016-2

Stimulation of incretin secreting cells

Ramona Pais, Fiona M. Gribble, Frank Reimann

Therapeutic Advances in Endocrinology and Metabolism

Search results